Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy

被引：3
|
作者：
Park, JH
Park, JH
Yang, CW
Kim, YS
Kim, SY
Moon, IS
Koh, YB
Bang, BK
机构：
[1] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Internal Med, Seocho Ku, Seoul 137040, South Korea
[2] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Surg, Seocho Ku, Seoul 137040, South Korea
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01393-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1747 / 1747
页数：1
相关论文
共 50 条
  • [21] Clinical experience of mycophenolate mofetil in the treatment of chronic allograft nephropathy in kidney transplantation: Three-year follow-up
    Chu, SH
    Wu, CT
    Chou, CC
    Chen, Y
    Liu, KL
    Chiang, YJ
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2073 - 2075
  • [22] Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy
    Henne, T
    Latta, K
    Strehlau, J
    Pape, L
    Ehrich, JHH
    Offner, G
    TRANSPLANTATION, 2003, 76 (09) : 1326 - 1330
  • [23] Chronic allograft nephropathy: Prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution
    McGrath, JS
    Shehata, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2193 - 2195
  • [24] Chronic allograft nephropathy: A prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
    Nicholson, ML
    Jain, S
    Metcalfe, M
    White, SA
    Furness, PN
    TRANSPLANTATION, 2000, 69 (08) : S227 - S227
  • [25] EFFECT OF MYCOPHENOLATE MOFETIL ON ALLOGRAFT ARTERIOSCLEROSIS (CHRONIC REJECTION)
    RAISANENSOKOLOWSKI, A
    MYLLARNIEMI, M
    HAYRY, P
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3225 - 3225
  • [26] Chronic renal allograft dysfunction: A role for mycophenolate mofetil?
    Pascual, M
    Williams, WW
    Cosimi, AB
    Delmonico, FL
    Farrell, ML
    Tolkoff-Rubin, N
    TRANSPLANTATION, 2000, 69 (08) : 1749 - 1750
  • [27] Long term outcome of mycophenolate mofetil addition to calcineurin-based immunosuppressive protocol in kidney transplant recipients with chronic allograft nephropathy
    Urbanowicz, Arkadiusz L.
    Perkowska, Agnieszka
    Cieciura, Tomasz
    Baczkowska, Teresa M.
    Pazik, Joanna
    Nowacka-Cieciura, Ewa
    Nazarewski, Slawomir
    Chmura, Andrzej
    Durlik, Magdalena
    TRANSPLANT INTERNATIONAL, 2007, 20 : 237 - 237
  • [28] Chronic renal allograft rejection - No response to mycophenolate mofetil
    Glicklich, D
    Gupta, B
    Schurter-Frey, G
    Greenstein, SM
    Schechner, RS
    Tellis, VA
    TRANSPLANTATION, 1998, 66 (03) : 398 - 399
  • [29] Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy
    Moscoso-Solorzano, G. T.
    Mastroinanni-Kirsztjan, G.
    Ozaki, K. S.
    Franco, M. F.
    Pacheco-Silva, A.
    Camara, N. O. S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (05) : 445 - 452
  • [30] Mycophenolate mofetil decreases the risk for chronic renal allograft failure
    Meier-Kriesche, HU
    Ojo, AO
    Arndorfer, JA
    Magee, JC
    Cibrik, DM
    Leichtman, AB
    Campbell, DA
    Kaplan, B
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1005 - 1006
12345